Bioastra Technologies inc.
$50,000.00 CAD
≈ 8 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- April 1, 2018 – January 4, 2019
- Reference
- nrc-cnrc:172-2018-2019-Q1-902664
Published purpose
In-vitro development of next generation glucose-sensitive implantable device for diabetes treatment based on smart sol-gel.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions